Biomarker and Genetic Predictors of Erenumab Treatment Response
Clinical trial NCT04265755 · COMPLETED
Trial details
- NCT number
- NCT04265755
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2023-01-18
- Enrollment
- 1406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.